Cresco Labs Inc (CRLBF)
2.10
-0.09
(-4.11%)
USD |
OTCM |
Apr 18, 16:00
Cresco Labs Net Income (Quarterly): 2.635M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.635M |
| September 30, 2023 | -115.57M |
| June 30, 2023 | -36.53M |
| March 31, 2023 | -26.05M |
| December 31, 2022 | -161.34M |
| September 30, 2022 | -9.788M |
| June 30, 2022 | -13.54M |
| March 31, 2022 | -27.38M |
| December 31, 2021 | -14.73M |
| September 30, 2021 | -270.64M |
| June 30, 2021 | -4.827M |
| March 31, 2021 | -29.39M |
| December 31, 2020 | -54.64M |
| September 30, 2020 | 15.46M |
| June 30, 2020 | -36.43M |
| March 31, 2020 | -26.54M |
| December 31, 2019 | -27.99M |
| September 30, 2019 | -6.96M |
| June 30, 2019 | -2.026M |
| March 31, 2019 | -6.227M |
| October 31, 2018 | -0.064M |
| July 31, 2018 | 0.115M |
| April 30, 2018 | -0.0208M |
| January 31, 2018 | -0.0421M |
| October 31, 2017 | -0.0132M |
| Date | Value |
|---|---|
| July 31, 2017 | -0.0166M |
| April 30, 2017 | -0.0131M |
| January 31, 2017 | -0.068M |
| October 31, 2016 | -0.0081M |
| July 31, 2016 | -0.0184M |
| April 30, 2016 | -0.0151M |
| January 31, 2016 | -0.0223M |
| October 31, 2015 | -0.0112M |
| July 31, 2015 | 0.1002M |
| April 30, 2015 | -0.0204M |
| January 31, 2015 | -0.0502M |
| October 31, 2014 | -0.0301M |
| July 31, 2014 | -0.0261M |
| April 30, 2014 | -0.0181M |
| January 31, 2014 | -0.0774M |
| October 31, 2013 | -0.0616M |
| July 31, 2013 | -0.0398M |
| April 30, 2013 | -0.0255M |
| January 31, 2013 | -0.1098M |
| October 31, 2012 | -0.0739M |
| July 31, 2012 | -0.0571M |
| April 30, 2012 | -0.1227M |
| January 31, 2012 | 0.0397M |
| October 31, 2011 | -0.0667M |
| July 31, 2011 | 0.077M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-270.64M
Minimum
Sep 2021
15.46M
Maximum
Sep 2020
-44.54M
Average
-26.54M
Median
Mar 2020
Net Income (Quarterly) Benchmarks
| Flora Growth Corp | -10.11M |
| Tilray Brands Inc | -92.70M |
| Clever Leaves Holdings Inc | -5.085M |
| Seelos Therapeutics Inc | -5.453M |
| Skye Bioscience Inc | -4.420M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 188.24M |
| Total Expenses (Quarterly) | 161.17M |
| EPS Diluted (Quarterly) | 0.0143 |
| Enterprise Value | 1.040B |
| Gross Profit Margin (Quarterly) | 51.08% |
| Profit Margin (Quarterly) | 1.40% |
| Earnings Yield | -25.51% |
| Operating Earnings Yield | 9.25% |
| Normalized Earnings Yield | -5.682 |